JOHN J. ALAM - 17 Nov 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Issuer symbol
CRVO
Transactions as of
17 Nov 2025
Net transactions value
+$182,736
Form type
4
Filing time
19 Nov 2025, 07:45:08 UTC
Previous filing
17 Nov 2025
Next filing
13 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ALAM JOHN J CEO & President, Director, 10%+ Owner 20 PARK PLAZA, SUITE 424, BOSTON /s/ William R. Elder, attorney-in-fact for the Reporting Person 19 Nov 2025 0001197014

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVO Common Stock Purchase $91,427 +10,807 +0.73% $8.46 1,484,078 17 Nov 2025 Direct F1, F2, F3
transaction CRVO Common Stock Purchase $91,309 +10,793 +632% $8.46 12,500 17 Nov 2025 Spouse's IRA F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased in open-market transactions.
F2 The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.39 to $8.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.
F3 Includes (i) 1,471,578 shares held jointly by the Reporting Person and his spouse, Dr. Sylvie Gregoire, PharmD., a member of the Issuer's Board of Directors and (ii) 12,500 shares held by the John J. Alam Roth IRA.
F4 Shares held by the Sylvie Gregoire Roth IRA.
F5 The price reported is a weighted average price. The shares were purchased in open-market transactions at prices ranging from $8.38 to $8.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full detail regarding the number of shares purchased at each separate price within such range.